164 related articles for article (PubMed ID: 27424888)
1. Evaluation of the influence of pharmacists and GPs on patient perceptions of long-term topical corticosteroid use.
Farrugia LL; Lee A; Fischer G; Blaszczynski A; Carter SR; Smith SD
J Dermatolog Treat; 2017 Mar; 28(2):112-118. PubMed ID: 27424888
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the influence of family and friends, and the Internet on patient perceptions of long-term topical corticosteroid use.
Smith SD; Farrugia LL; Harris V; Lee A; Carter SR; Blaszczynski A; Fischer G
J Dermatolog Treat; 2017 Nov; 28(7):642-646. PubMed ID: 28349719
[TBL] [Abstract][Full Text] [Related]
3. Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education.
Smith SD; Lee A; Blaszczynski A; Fischer G
Australas J Dermatol; 2016 Aug; 57(3):199-204. PubMed ID: 25846602
[TBL] [Abstract][Full Text] [Related]
4. The perspectives of parents, general practitioners, and community pharmacists about treating an ill child in primary care: a comparative study.
Verhelst S; De Bruyne P; Van Winckel M; Boussery K; Tommelein E
Eur J Pediatr; 2020 Jan; 179(1):111-119. PubMed ID: 31659469
[TBL] [Abstract][Full Text] [Related]
5. Pediatric medication use experiences and patient counseling in community pharmacies: Perspectives of children and parents.
Abraham O; Brothers A; Alexander DS; Carpenter DM
J Am Pharm Assoc (2003); 2017; 57(1):38-46.e2. PubMed ID: 27843107
[TBL] [Abstract][Full Text] [Related]
6. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
Hamrosi KK; Raynor DK; Aslani P
Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
[TBL] [Abstract][Full Text] [Related]
7. Community pharmacists' knowledge, perceptions, and practices about topical corticosteroid counseling: A real-world cross-sectional survey and focus group discussions in Korea.
Kang MJ; Park JH; Park S; Kim NG; Kim EY; Yu YM; Kim DY; Lee JY; Shin WG; Choi SA
PLoS One; 2020; 15(7):e0236797. PubMed ID: 32726366
[TBL] [Abstract][Full Text] [Related]
8. Assessment of "corticophobia" as an indicator of non-adherence to topical corticosteroids: A pilot study.
Mueller SM; Itin P; Vogt DR; Walter M; Lang U; Griffin LL; Euler S
J Dermatolog Treat; 2017 Mar; 28(2):104-111. PubMed ID: 27396480
[TBL] [Abstract][Full Text] [Related]
9. Community pharmacists' counseling practices and patient experiences about topical corticosteroids - an online survey in the Klang Valley, Malaysia.
Nathan AD; Shankar PR; Sreeramareddy CT
BMC Prim Care; 2022 Oct; 23(1):263. PubMed ID: 36243689
[TBL] [Abstract][Full Text] [Related]
10. Prescribing or dispensing medication represents the best opportunity for GPs and pharmacists to engage older people in alcohol-related clinical conversations.
Wilkinson C; Dare J; French M; McDermott ML; Lo J; Allsop S
Int J Pharm Pract; 2016 Oct; 24(5):319-25. PubMed ID: 26871545
[TBL] [Abstract][Full Text] [Related]
11. General practitioner-pharmacist interactions in professional pharmacy services.
Van C; Mitchell B; Krass I
J Interprof Care; 2011 Sep; 25(5):366-72. PubMed ID: 21657854
[TBL] [Abstract][Full Text] [Related]
12. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.
Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P
J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a measure and a model of general practitioner attitudes toward collaboration with pharmacists.
Van C; Costa D; Mitchell B; Abbott P; Krass I
Res Social Adm Pharm; 2013; 9(6):688-99. PubMed ID: 23395533
[TBL] [Abstract][Full Text] [Related]
14. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
Shaeer KM; Sherman EM; Shafiq S; Hardigan P
J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
[TBL] [Abstract][Full Text] [Related]
15. Physician and pharmacist perceptions of generic medicines: what they think and how they differ.
Dunne S; Shannon B; Hannigan A; Dunne C; Cullen W
Health Policy; 2014 Jun; 116(2-3):214-23. PubMed ID: 24709114
[TBL] [Abstract][Full Text] [Related]
16. Perceptions of pharmacists and patients on information provision and their influence on patient satisfaction in Japanese community pharmacies.
Takaki H; Abe T; Hagihara A
J Eval Clin Pract; 2015 Dec; 21(6):1135-41. PubMed ID: 26268798
[TBL] [Abstract][Full Text] [Related]
17. Exploring the nature of power distance on general practitioner and community pharmacist relations in a chronic disease management context.
Rieck AM
J Interprof Care; 2014 Sep; 28(5):440-6. PubMed ID: 24716620
[TBL] [Abstract][Full Text] [Related]
18. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.
Hatah E; Braund R; Duffull SB; Tordoff J
J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173
[TBL] [Abstract][Full Text] [Related]
19. Exploring the General Practitioner-pharmacist relationship in the community setting in Ireland.
Moore T; Kennedy J; McCarthy S
Int J Pharm Pract; 2014 Oct; 22(5):327-34. PubMed ID: 24433551
[TBL] [Abstract][Full Text] [Related]
20. Avoiding acute kidney injury in primary care: attitudes and behaviours of general practitioners and community pharmacists in Hawke's Bay.
Vicary D; Hutchison C; Aspden T
J Prim Health Care; 2020 Sep; 12(3):244-256. PubMed ID: 32988446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
